The Beachbody Company, Inc.
The Beachbody Company, Inc. (BODI) Financial Performance & Income Statement Overview
Analyze The Beachbody Company, Inc. (BODI) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
The Beachbody Company, Inc. (BODI) Income Statement & Financial Overview
Explore comprehensive income reports for The Beachbody Company, Inc. BODI, broken down by year and quarter.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $72.36M | $86.37M | $102.19M | $110.18M |
Cost of Revenue | $20.81M | $25.50M | $33.38M | $33.81M |
Gross Profit | $51.55M | $60.88M | $68.81M | $76.38M |
Gross Profit Ratio | $0.71 | $0.70 | $0.67 | $0.69 |
R&D Expenses | $12.60M | $22.11M | $19.38M | $17.16M |
SG&A Expenses | $42.63M | $50.54M | $57.35M | $68.70M |
Operating Expenses | $55.22M | $93.77M | $76.73M | $85.86M |
Total Costs & Expenses | $76.04M | $98.15M | $110.12M | $119.67M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | -$1.56M | $1.71M | $1.65M | $1.65M |
Depreciation & Amortization | $0.00 | $15.82M | $11.84M | $9.52M |
EBITDA | -$3.67M | -$17.03M | $1.60M | $377000.00 |
EBITDA Ratio | -$0.05 | -$0.20 | $0.02 | $0.003 |
Operating Income | -$3.67M | -$32.89M | -$7.92M | -$9.48M |
Operating Income Ratio | -$0.05 | -$0.38 | -$0.08 | -$0.09 |
Other Income/Expenses (Net) | -$2.03M | -$1.67M | -$3.96M | -$1.32M |
Income Before Tax | -$5.70M | -$34.56M | -$11.89M | -$10.80M |
Income Before Tax Ratio | -$0.08 | -$0.40 | -$0.12 | -$0.10 |
Income Tax Expense | -$45000.00 | -$5000.00 | $115000.00 | $67000.00 |
Net Income | -$5.75M | -$34.56M | -$12.003M | -$10.87M |
Net Income Ratio | -$0.08 | -$0.40 | -$0.12 | -$0.10 |
EPS | -$0.84 | -$5.04 | -$1.75 | -$1.59 |
Diluted EPS | -$0.84 | -$5.04 | -$1.75 | -$1.59 |
Weighted Avg Shares Outstanding | $6.88M | $6.86M | $6.84M | $6.81M |
Weighted Avg Shares Outstanding (Diluted) | $6.88M | $6.86M | $6.84M | $6.81M |
Financial performance has remained strong, with revenue growing from $110.18M in Q2 2024 to $72.36M in Q1 2025. Gross profit continued to perform well, with margins at 71% in the latest quarter. Operating income reached -$3.67M in Q1 2025, holding a steady -5% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$3.67M. Net income rose to -$5.75M, keeping EPS at -$0.84. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan